https://doi.org/10.4081/monaldi.2025.3281
Bronchoscopic valve therapy for tuberculosis: a scoping review
Submitted: November 29, 2024
Accepted: January 8, 2025
Published: March 5, 2025
Accepted: January 8, 2025
Abstract Views: 328
PDF_EARLY VIEW: 100
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The management of tuberculosis (TB) presents significant challenges, particularly in the context of multidrug-resistant TB (MDR-TB) and TB-HIV co-infection. Traditional surgical interventions, such as lung resection and pneumothorax induction, have largely been phased out with the advent of modern antibiotic regimens. However, emerging evidence suggests that endobronchial interventions, specifically the use of unidirectional valves, have potential in supporting the treatment of MDR-TB. The objective of this review is to demonstrate the feasibility of closure of tubercular cavities using endobronchial valves, resulting in improved clinical outcomes and sputum smear conversion. PubMed was searched from inception to September 2024. The small studies reviewed here demonstrate the feasibility of tubercular cavity closure using endobronchial valves, resulting in improved clinical outcomes and sputum smear conversion. Yet, limited access to Food and Drug Administration-approved valves and funding challenges hinders large-scale trials. To address these limitations, further evidence is needed within improved international collaboration. We suggest that international prospective trials and innovation are needed. Such collaborative efforts would clarify the role of valves in TB treatment and hopefully lead to the development of simpler and more affordable occlusive devices that would benefit patients with MDR-TB, particularly in low-income countries.
World Health Organization. Global tuberculosis report: 2022. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022.
Marrone MT, Venkataramanan V, Goodman M, et al. Surgical interventions for drug-resistant tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis 2013;17:6-16.
DOI: https://doi.org/10.5588/ijtld.12.0198
Calligaro GL, Moodley L, Symons G, Dheda K. The medical and surgical treatment of drug-resistant tuberculosis. J Thorac Dis 2014;6:186-95.
Drain PK, Bajema KL, Dowdy D, et al. Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection. Clin Microbiol Rev 2018;31:e00021-18.
DOI: https://doi.org/10.1128/CMR.00021-18
Paton NI, Cousins C, Suresh C, et al. Treatment strategy for rifampin-susceptible tuberculosis. N Engl J Med 2023;388:873-87.
DOI: https://doi.org/10.1056/NEJMoa2212537
WHO. WHO consolidated guidelines on tuberculosis: module 4: treatment - drug-susceptible tuberculosis treatment. 2022. Available from: https://www.who.int/publications/i/item/9789240048126.
Edessa D, Sisay M, Dessie Y. Unfavorable outcomes to second-line tuberculosis therapy among HIV-infected versus HIV-uninfected patients in sub-Saharan Africa: a systematic review and meta-analysis. PLoS One 2020;15:e0237534.
DOI: https://doi.org/10.1371/journal.pone.0237534
Kempker RR, Vashakidze S, Solomonia N, et al. Surgical treatment of drug-resistant tuberculosis. Lancet Infect Dis 2012;12:157-66.
DOI: https://doi.org/10.1016/S1473-3099(11)70244-4
Toma TP, Hopkinson NS, Hillier J, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet 2003;361:931-3.
DOI: https://doi.org/10.1016/S0140-6736(03)12762-6
Criner GJ, Wright S, Sue R, et al. Effectiveness of the zephyr® endobronchial valves (EBV®) in patients with severe emphysema: clinical outcomes from liberate, a multicenter RCT. Am J Respir Crit Care Med 2018;198:1151-64.
DOI: https://doi.org/10.1164/rccm.201803-0590OC
Corbetta L, Tofani A, Montinaro F, et al. Lobar collapse therapy using endobronchial valves as a new complementary approach to treat cavities in multidrug-resistant tuberculosis and difficult-to-treat tuberculosis: a case series. Respiration 2016;92:316-28.
DOI: https://doi.org/10.1159/000450757
Levin A, Sklyuev S, Felker I, et al. Endobronchial valve treatment of destructive multidrugresistant tuberculosis. Int J Tuberc Lung Dis 2016;20:1539-45.
DOI: https://doi.org/10.5588/ijtld.16.0033
An H, Liu X, Wang T, et al. Endobronchial valve treatment of tuberculous cavities in patients with multidrug-resistant pulmonary tuberculosis: a randomized clinical study. Pathogens 2022;11:899.
DOI: https://doi.org/10.3390/pathogens11080899
Popova LA, Shergina EA, Lovacheva OV, et al. Change in lung function early after endoscopic bronchial valve placement in patients with chronic cavitary tuberculosis. Pulmonologiya 2018;28:332-40.
DOI: https://doi.org/10.18093/0869-0189-2018-28-3-332-340
Popova LA, Shergina EA, Bagdasaryan TP, et al. The change of ventilation and gas exchange function of the lungs as the result of endoscopic valvular bronchial blocking in patients with recurrent fibro-cavernous tuberculosis after lung resection. Medical Alphabet 2019;3:8-15.
DOI: https://doi.org/10.33667/2078-5631-2019-3-29(404)-8-15
Togo T, Atsumi J, Hiramatsu M, et al. A novel approach to extensive clarithromycin-resistant mycobacterium avium complex pulmonary disease. Ann Thorac Cardiovasc Surg 2022;28:444-7.
DOI: https://doi.org/10.5761/atcs.cr.21-00010
Song X, Gu Y, Wang H, Zhang L. The efficacy of endobronchial valves for the treatment of bronchopleural fistula: a single-arm clinical trial. J Thorac Dis 2022;14:712-20.
DOI: https://doi.org/10.21037/jtd-22-258
Lalla U, Allwood BW, Sinha Roy S, et al. Endobronchial valve used as salvage therapy in a mechanically ventilated patient with intractable life-threatening haemoptysis. Respiration 2017;93:436-40.
DOI: https://doi.org/10.1159/000465526
Diab K, Rieger K, Noor A. Endobronchial valve placement for pulmonary tuberculosis-related bronchocutaneous fistula after thoracoplasty. J Bronchology Interv Pulmonol 2020;27:294-6.
DOI: https://doi.org/10.1097/LBR.0000000000000688
Gompelmann D, Dheda K. Endoscopic valve therapy: a new therapeutic approach for otherwise incurable tuberculosis? Respiration 2017;93:79-80.
DOI: https://doi.org/10.1159/000453621
How to Cite
Agarwal, Kshitij, Adam T. Gray, Tudor P. Toma, Valentina Luzzi, and Lorenzo Corbetta. 2025. “Bronchoscopic Valve Therapy for Tuberculosis: A Scoping Review”. Monaldi Archives for Chest Disease, March. https://doi.org/10.4081/monaldi.2025.3281.
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Gabriele Valli, Francesca De Marco, Maria Teresa Spina, Valentina Valeriano, Antonello Rosa, Valentina Minerva, Enrico Mirante, Maria Pia Ruggieri, Francesco Rocco Pugliese, A pilot study on the application of the current European guidelines for the management of acute coronary syndrome without elevation of ST segment (NSTEMI) in the Emergency Department setting in the Italian region Lazio , Monaldi Archives for Chest Disease: Vol. 82 No. 4 (2014): Cardiac series
- Domenico Galzerano, Claudio Pragliola, Mohamed Al Admawi, Mario Mallardo, Sara Di Michele, Carlo Gaudio, The role of 3D echocardiographic imaging in the differential diagnosis of an atypical left atrial myxoma , Monaldi Archives for Chest Disease: Vol. 88 No. 3 (2018)
- Roberto F.E. Pedretti, Francesco Fattirolli, Raffaele Griffo, Marco Ambrosetti, Elisabetta Angelino, Silvia Brazzo, Ugo Corrà , Nicolò Dasseni, Pompilio Faggiano, Giuseppe Favretto, Oreste Febo, Marina Ferrari, Francesco Giallauria, Cesare Greco, Manuela Iannucci, Maria Teresa La Rovere, Mario Mallardo, Antonio Mazza, Massimo Piepoli, Carmine Riccio, Simonetta Scalvini, Luigi Tavazzi, Pier Luigi Temporelli, Gian Francesco Mureddu, Cardiac Prevention and Rehabilitation “3.0â€: From acute to chronic phase. Position Paper of the ltalian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR) , Monaldi Archives for Chest Disease: Vol. 88 No. 3 (2018)
- Lilit Khachatryan, Ruzanna Grigoryan, Andrei Dadu, Ajay M.V. Kumar, Kristina Akopyan, Kostyantyn Dumchev, Hasmik Harutyunyan, Alberto Matteelli, Factors associated with unfavourable treatment outcomes among people with rifampicin-resistant tuberculosis in Armenia, 2014-2017 , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Varvara Solodovnikova, Ajay M.V. Kumar, Hennadz Hurevich, Yuliia Sereda, Vera Auchynka, Dzmitry Katovich, Dzmitry Klimuk, Aliaksandr Skrahin, Svetlana Setkina, Iryna Charnysh, Askar Yedilbayev, Alena Skrahina, Effectiveness and safety of delamanid- or bedaquiline-containing regimens among children and adolescents with multidrug resistant or extensively drug resistant tuberculosis: A nationwide study from Belarus, 2015-19 , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- R. Luzzati, M. Confalonieri, A. Cazzadori, P. Della Loggia, R. Cifaldi, C. Fabris, M. Biolo, M. Borelli, C. Longo, E. Concia, Prolonged hospitalisation for immigrants and high risk patients with positive smear pulmonary tuberculosis , Monaldi Archives for Chest Disease: Vol. 75 No. 2 (2011): Pulmonary series
- L.R. Codecasa, M. Ferrarese, V. Penati, C. Lacchini, D. Cirillo, C. Scarparo, P. Piccoli, C. Piersimoni, G.B. Migliori, Comparison of Tuberculin Skin test and Quantiferon immunological assay for latent Tuberculosis infection , Monaldi Archives for Chest Disease: Vol. 63 No. 3 (2005): Pulmonary series
- T. Kinnunen, O. Säynäjäkangas, T. Keistinen, Features of hospitalisations for acute exacerbation of COPD resulting in death , Monaldi Archives for Chest Disease: Vol. 67 No. 1 (2007): Pulmonary series
- Neeta Singla, Amitesh Gupta, U.K. Khalid, Ravindra Kumar Dewan, Rupak Singla, Clinical profile, risk factors, disease severity, and outcome for COVID-19 disease in patients with tuberculosis on treatment under the National Tuberculosis Elimination Program: a cohort of 1400 patients , Monaldi Archives for Chest Disease: Early Access
- Rupak Singla, Amitesh Gupta, Vikas Kumar, Chandrasekaran Padmapriyadarsini, Devika Tayal, Shweta Anand, Abhishek Faye, AK Hemanth Kumar, Madhumita Paul Choudhary, Study of risk factors and clinical management of patients with clinical non-response due to low plasma levels of anti-tubercular drugs , Monaldi Archives for Chest Disease: Early Access
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.
